Medication assisted treatments (MAT) enhance opioid use disorder treatment efficacy, yet remain underutilized. Opioid treatment programs (OTPs) can now dispense buprenorphine or naltrexone as well as methadone. Collaboration between OTPs and office-based buprenorphine (OBB) prescribers constitutes a cohesive model providing access to comprehensive services, and encouraging MAT prescribing. Dr. Stoller will focus on a model of care he coined “Collaborative Opioid Prescribing (CoOP),” linking OTP expertise with OBB prescribers. The OTP provides assessment, buprenorphine induction, and counseling, while OBB physicians provide ongoing buprenorphine prescribing and somatic or psychiatric care. An adaptive stepped care model adjusts counseling intensity and medication parameters (OBB prescription vs. OTP dispensing; duration of prescriptions). Supporting OBB providers in this manner may encourage MAT provision and access, while concurrently improving treatment outcome. Providing a broad spectrum of medical, social, and recovery services through coordinated care can enhance health outcomes and address unmet patient needs.
Funding for this initiative was made possible (in part) by grant no. 5U79TI026556-03 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. pcssnow.org
- General Member - Free
- Resident-Fellow Member - Free
- Medical Student Member - Free
- Non-Member - Free
- Describe a model of treatment that links opioid treatment programs with office-based buprenorphine prescribers.
- List at least two reasons physicians often give as reasons why they do not prescribe buprenorphine.
- Provide one definition of the term “clinical integration.”
Physicians who have a waiver to treat opioid use disorder in an office-based setting and other interested clinicians
Estimated Time to Complete
Estimated Duration: 1 Hour
Start Date: June 14, 2016
Review Date: June 14, 2019
End Date: June 14, 2020
How to Earn Credit
Participants who wish to earn AMA PRA Category 1 Credit ™ or a certificate of participation may do so by completing all sections of the course including the evaluation. A multiple choice quiz is provided based on the content. A passing score of 60% must be achieved. Retakes are available for the test. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the event date and hours earned.
Continuing Education Credit
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The APA designates this enduring CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
- Kenneth B. Stoller, M.D., Assistant Professor, Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine. Reports no financial relationships with commercial interests.
- Andrew Saxon, M.D., Professor, Department of Psychiatry & Behavioral Sciences; Director, Addiction Psychiatry Residency Program, University of Washington; Director, Center of Excellence in Substance Abuse Treatment and Education (CESATE) VA Puget Sound Health Care System. Reports no financial relationships with commercial interests.
- Beatrice Eld, Deputy Director of Educaton for Addiction Psychiatry, American Psychiatric Association. Reports no financial relationships with commercial interests
- Frances R. Levin, M.D., Kennedy Leavy Professor of Psychiatry at Columbia University Medical Center; Director, Addiction Psychiatry Fellowship, New York Presbyterian Hospital; Director of Clinical and Educational Activities for the Division on Substance Abuse, New York State Psychiatric Institute. Disclosure: Consultant: Major League Baseball, Grant/Research Support: US World Med.
- John A. Renner, Jr., M.D.– Boston University School of Medicine, Director, Addiction Psychiatry Residency Training, Boston University Medical Center and VA Boston Healthcare System. Disclosure: Stock/other financial options: Johnson & Johnson and General Electric.
Program Reviewers (June 14, 2019)
- John A. Renner, Jr., M.D., Boston University School of Medicine, Director, Addiction Psychiatry Residency Training, Boston University Medical Center and VA Boston Healthcare System. Disclosure: Stock/other financial options: Johnson & Johnson and General Electric.
Optimal System Configuration:
- Flash Player: Adobe Flash Player 10.3+
- Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
- Operating System: Windows XP+ or Mac OS X 10.4+
- Internet Connection: 1 Mbps or higher
- Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
- Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content
For assistance: Contact firstname.lastname@example.org questions about this course | Contact email@example.com for technical assistance
All materials copyright American Psychiatric Association. ©2013-2016
American Psychiatric Association
Department of CME
1000 Wilson Blvd
Arlington, VA 22209